Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
November 30, 2004
Primary Completion Date
February 28, 2007
Conditions
Ovarian CancerPeritoneal Cavity Cancer
Interventions
DRUG
ixabepilone
Trial Locations (1)
10461
Albert Einstein Cancer Center at Albert Einstein College of Medicine, The Bronx
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Montefiore Medical Center
OTHER
NCT00030706 - Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter